CompaniesRobotics and AIUpdated Oct 15, 2026
Undecimal Bio
Private. Undecimal pairs massive scale combinatorial chemistry with transformer-based AI to guide siRNA therapeutics into the tissues that need them.
- Last round
- Not recorded
- Backed by
- Not recorded
- Launched
- Not recorded
- People
- 4
Overview
Updated Oct 15, 2026
Every fact carries a numbered source. Where we can't source something, it says so.
Identity fields from the company record are sourced where a source is recorded; those have no number.
Funding Not recorded
Opportunities For accredited investors
Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.
Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.
No live opportunities right now. Accredited investors are notified first when one opens.
Create an accredited profileA vehicle is never smaller than $1,000,000.
People
Who founded and leads Undecimal Bio?
Names and titles only, each sourced.
Sources
Every claim on this page traces to one of these. The numbers match the citations above.
- 1UndecimalBio | AI-Driven siRNA Delivery opens in a new tabHeadquarters, Sector, Website, People · accessed Oct 14, 2026